Secondary |
Acute Coronary Syndrome |
23.7% |
Product Used For Unknown Indication |
21.2% |
Coronary Artery Disease |
6.8% |
Hypertension |
6.8% |
Acute Myocardial Infarction |
4.2% |
Anticoagulant Therapy |
4.2% |
Prophylaxis |
4.2% |
Pain Management |
3.4% |
Stent Placement |
3.4% |
Arthralgia |
2.5% |
Atrial Fibrillation |
2.5% |
Depression |
2.5% |
Plasma Cell Myeloma |
2.5% |
Arthritis |
1.7% |
Cardiac Disorder |
1.7% |
Drug Use For Unknown Indication |
1.7% |
Heart Rate Increased |
1.7% |
Pain |
1.7% |
Sciatica |
1.7% |
Thrombosis Prophylaxis |
1.7% |
|
Thrombocytopenia |
16.7% |
Thrombosis In Device |
12.5% |
Gastrointestinal Haemorrhage |
8.3% |
Pain In Extremity |
8.3% |
Pneumonia |
8.3% |
Productive Cough |
8.3% |
Cytolytic Hepatitis |
4.2% |
Gastric Ulcer |
4.2% |
Haematoma |
4.2% |
Hyponatraemia |
4.2% |
Laryngeal Oedema |
4.2% |
Malaise |
4.2% |
Rectal Adenocarcinoma |
4.2% |
Vasculitis |
4.2% |
Weight Fluctuation |
4.2% |
|
Concomitant |
Product Used For Unknown Indication |
54.3% |
Plasma Cell Myeloma |
10.6% |
Drug Use For Unknown Indication |
6.9% |
Hypertension |
4.9% |
Prophylaxis |
4.9% |
Thrombosis Prophylaxis |
3.6% |
Multiple Myeloma |
3.5% |
Pain |
2.1% |
Diabetes Mellitus |
1.1% |
Depression |
0.9% |
Atrial Fibrillation |
0.8% |
Anticoagulant Therapy |
0.8% |
Myocardial Ischaemia |
0.8% |
Diffuse Large B-cell Lymphoma |
0.7% |
Cardiac Failure |
0.7% |
Nausea |
0.7% |
Rheumatoid Arthritis |
0.7% |
Anxiety |
0.6% |
Constipation |
0.6% |
Gastrooesophageal Reflux Disease |
0.6% |
|
Vomiting |
9.2% |
Plasma Cell Myeloma |
8.6% |
Weight Decreased |
7.5% |
Renal Failure Acute |
6.9% |
Pneumonia |
6.3% |
Tremor |
6.3% |
White Blood Cell Count Increased |
5.7% |
Death |
4.6% |
Squamous Cell Carcinoma Of Skin |
4.6% |
Thrombocytopenia |
4.6% |
Acute Myeloid Leukaemia |
4.0% |
Malaise |
4.0% |
Myocardial Infarction |
4.0% |
Rash |
4.0% |
Basal Cell Carcinoma |
3.4% |
Drug Ineffective |
3.4% |
Thrombosis |
3.4% |
Weight Increased |
3.4% |
Headache |
2.9% |
Subdural Haematoma |
2.9% |
|
Interacting |
|
Haemorrhagic Anaemia |
100.0% |
|